ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
152 hedge funds and large institutions have $1.26B invested in Acorda Therapeutics in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 40 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less call options, than puts
Call options by funds: $6.72M | Put options by funds: $8.28M
Holders
152
Holding in Top 10
1
Calls
$6.72M
Puts
$8.28M
Top Buyers
| 1 | +$34.6M | |
| 2 | +$29.6M | |
| 3 | +$16.6M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$12.3M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$10.2M |
Top Sellers
| 1 | -$21.9M | |
| 2 | -$12.7M | |
| 3 | -$7.88M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$6.88M |
| 5 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$5.32M |